SOPHiA GENETICS Schedules Q2 2024 Financial Results Announcement

Curated by THEOUTPOST

On Tue, 23 Jul, 4:05 PM UTC

2 Sources

Share

SOPHiA GENETICS, a cloud-native software company in the healthcare space, has announced it will release its financial results for the second quarter of 2024 on August 6, 2024. The company will also host a conference call to discuss the results on the same day.

SOPHiA GENETICS Sets Date for Q2 2024 Financial Results

SOPHiA GENETICS SA (Nasdaq: SOPH), a leading cloud-native software company in the healthcare sector, has announced the date for its second quarter 2024 financial results release. The company will unveil its financial performance on Tuesday, August 6, 2024, before the U.S. financial markets open 1.

Conference Call Details

Following the release of the financial results, SOPHiA GENETICS will host a conference call and webcast at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time on the same day. This call will provide an opportunity for investors and analysts to delve deeper into the company's performance and future outlook 2.

Accessing the Conference Call

Interested parties can access the live call through various means:

  1. Webcast: A live and archived webcast will be available on the company's website in the Investor Relations section 1.
  2. Telephone: Participants can join via telephone by dialing 1-877-270-2148 (US) or 1-412-902-6510 (International) 2.

To ensure a timely connection, it is recommended that participants join at least 15 minutes before the call begins 1.

About SOPHiA GENETICS

SOPHiA GENETICS is at the forefront of data-driven medicine, leveraging AI and machine learning to develop innovative technologies for healthcare professionals. The company's platform, SOPHiA DDM, is designed to analyze and interpret complex genomic data, assisting in clinical decision making across various medical disciplines including oncology, rare diseases, and cardiology 12.

Investor Relations and Further Information

For those unable to attend the live call, a replay will be available on the company's website shortly after the conference concludes. Additionally, SOPHiA GENETICS maintains an investor relations section on their website where stakeholders can find more information about the company's financial performance and strategic initiatives 12.

This upcoming financial results announcement is expected to provide valuable insights into SOPHiA GENETICS' performance in the rapidly evolving field of AI-driven healthcare solutions. As the company continues to expand its reach and refine its technologies, investors and industry observers alike will be keen to see how these developments translate into financial outcomes for the second quarter of 2024.

Continue Reading
SOPHiA GENETICS Showcases Advancements in Cancer Care at

SOPHiA GENETICS Showcases Advancements in Cancer Care at ESMO 2024

SOPHiA GENETICS announces updates on its SOPHiA UNITY platform and poster presentations at the European Society for Medical Oncology (ESMO) 2024 Congress, highlighting progress in precision medicine for cancer treatment.

Investing.com UK logo

2 Sources

Investing.com UK logo

2 Sources

SOPHiA GENETICS Expands Partnership with Canadian Oncology

SOPHiA GENETICS Expands Partnership with Canadian Oncology Lab OncoHelix

SOPHiA GENETICS, a cloud-native software company in the healthcare space, has announced an expanded relationship with OncoHelix, a Canadian molecular diagnostics laboratory. This partnership aims to enhance cancer care through advanced genomic analysis.

Market Screener logoBenzinga logo

2 Sources

Market Screener logoBenzinga logo

2 Sources

SOPHiA GENETICS Unveils Groundbreaking AI-Driven Patient

SOPHiA GENETICS Unveils Groundbreaking AI-Driven Patient Stratification Research at ESMO 2024

SOPHiA GENETICS presents innovative multimodal research on AI-driven patient stratification at ESMO 2024, showcasing advancements in precision medicine for cancer treatment.

Investing.com UK logoMarket Screener logo

2 Sources

Investing.com UK logoMarket Screener logo

2 Sources

Veracyte Announces Release Date for Q2 2024 Financial

Veracyte Announces Release Date for Q2 2024 Financial Results

Veracyte, Inc., a leading genomic diagnostics company, has scheduled the release of its second quarter 2024 financial results for August 6, 2024, after the close of the U.S. stock market. The company will also host a conference call to discuss the results and provide a business update.

Investing.com UK logoMarket Screener logo

2 Sources

Investing.com UK logoMarket Screener logo

2 Sources

Sapiens International Corporation to Release Q2 2024

Sapiens International Corporation to Release Q2 2024 Financial Results on August 1, 2024

Sapiens International Corporation N.V. has announced that it will publish its financial results for the second quarter of 2024 on August 1, 2024. The company will also host a conference call and webcast on the same day to discuss the results.

Market Screener logoBenzinga logo

2 Sources

Market Screener logoBenzinga logo

2 Sources

TheOutpost.ai

Your one-stop AI hub

The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.

© 2025 TheOutpost.AI All rights reserved